Physician profile
Dalisa Gutter
NPI 1659957785
$810.69
in general payments reported to CMS, 2019-2025
12 companies · $330 in 2025
The $330 reported for 2025 was more than what 77% of Women'S Health (Nurse Practitioner) providers received nationally (typical 2025 total: $123).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $101 · 2022: $73.07 · 2023: $104 · 2024: $203 · 2025: $330.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $637.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $636.63 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astellas Pharma US INC | $205.63 | 2022-2025 | Veozah |
| Abbvie INC. | $115.22 | 2021-2025 | |
| Mayne Pharma Commercial LLC | $90.83 | 2025 | |
| Pfizer INC. | $65.90 | 2024-2025 | |
| Bayer Healthcare Pharmaceuticals INC. | $57.83 | 2023-2025 | |
| Sumitomo Pharma America, INC. | $56.57 | 2023-2024 | Myfembree |
| Becton, Dickinson and Company | $48.83 | 2024 | Bd Max System, Bd Max Instrument |
| Vertex Pharmaceuticals Incorporated | $45.63 | 2024-2025 | |
| Optumhealth Care Solutions, LLC | $40.44 | 2024 | Eitan Medical, Vivify Health Care Team Portal 001 |
| Medtronic, INC. | $38.68 | 2025 | Signia |
| Organon LLC | $29.42 | 2025 | Nexplanon |
| Exact Sciences Corporation | $15.71 | 2025 | Cologuard Collection Kit |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Dalisa Gutter listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.